Cargando…
Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review
Retroperitoneal fibrosis (RPF) is a progressive fibroinflammatory disease that can be complicated by urinary obstruction. RPF can be the only manifestation of IgG4-related disease (IgG4-RD). Treatment of IgG4-related RPF is challenging and mostly consists of long-term glucocorticoids leading to sign...
Autores principales: | Almeqdadi, Mohammad, Al-Dulaimi, Mohammed, Perepletchikov, Aleksandr, Tomera, Kevin, Jaber, Bertrand L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933309/ https://www.ncbi.nlm.nih.gov/pubmed/29845002 http://dx.doi.org/10.5414/CNCS109321 |
Ejemplares similares
-
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
por: Wallwork, Rachel, et al.
Publicado: (2018) -
Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis
por: Wang, Kunkun, et al.
Publicado: (2021) -
Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis
por: Yamakawa, Hideaki, et al.
Publicado: (2017) -
Unilateral Leg Edema and Hydronephrosis in IgG4-Related Retroperitoneal Fibrosis
por: Kobayashi, Takahiro, et al.
Publicado: (2023) -
Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio
por: Choi, Su Jin, et al.
Publicado: (2021)